Want to see JP:4526 full AI Analyst Report?
Riken Vitamin Co., Ltd. (4526) Stock Statistics & Valuation Metrics
Total Valuation
Riken Vitamin Co., Ltd. has a market cap or net worth of JPY 78.33B. The enterprise value is JPY 78.70B.
- Market Cap
- JPY 78.33B
- Enterprise Value
- JPY 78.70B
Share Statistics
Riken Vitamin Co., Ltd. has 30,705,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 30,705,100
- Owned by Insiders
- ―
- Owned by Institutions
- 6.28%
Financial Efficiency
Riken Vitamin Co., Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.80%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 4.80%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 51.03M
- Profits Per Employee
- 3.73M
- Employee Count
- 1,887
- Asset Turnover
- 0.83
- Inventory Turnover
- 3.02
Valuation Ratios
The current PE Ratio of Riken Vitamin Co., Ltd. is 14.24. Riken Vitamin Co., Ltd.’s PEG ratio is -0.80.
- PE Ratio
- 14.24
- PS Ratio
- 1.02
- PB Ratio
- 1.19
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.80
Income Statement
In the last 12 months, Riken Vitamin Co., Ltd. had revenue of 96.30B and earned 7.04B in profits. Earnings per share was 238.17.
- Revenue
- 96.30B
- Gross Profit
- 29.77B
- Operating Income
- 6.90B
- Pretax Income
- 10.24B
- Net Income
- 7.04B
- EBITDA
- 11.58B
- Earnings Per Share (EPS)
- 238.17
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Riken Vitamin Co., Ltd. pays an annual dividend of JPY 55.00, resulting in a dividend yield of 3.20%
- Dividend Per Share
- JPY 55.00
- Dividend Yield
- 3.20%
- Payout Ratio
- 46.18%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 7.07%
Stock Price Statistics
- Beta
- 0.35
- 52-Week Price Change
- 22.77%
- 50-Day Moving Average
- 3244.90
- 200-Day Moving Average
- 3009.22
- Relative Strength Index (RSI)
- 67.69
- Average Volume (3m)
- 90.98K
Important Dates
Riken Vitamin Co., Ltd. upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 07, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- Sep 29, 2026
Financial Position
Riken Vitamin Co., Ltd. as a current ratio of 3.41, with Debt / Equity ratio of 8.57%
- Current Ratio
- 3.41
- Quick Ratio
- 2.27
- Debt to Market Cap
- 0.08
- Net Debt to EBITDA
- -1.12
- Interest Coverage Ratio
- 60.54
Taxes
In the past 12 months, Riken Vitamin Co., Ltd. has paid 3.20B in taxes.
- Income Tax
- 3.20B
- Effective Tax Rate
- 0.31
Enterprise Valuation
Riken Vitamin Co., Ltd. EV to EBITDA ratio is 7.50, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.91
- EV to EBITDA
- 7.50
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Riken Vitamin Co., Ltd. has JPY 17.91B in cash and marketable securities with JPY 7.40B in debt, giving a net cash position of JPY 10.50B billion.
- Cash & Marketable Securities
- JPY 17.91B
- Total Debt
- JPY 7.40B
- Net Cash
- JPY 10.50B
- Net Cash Per Share
- JPY 342.03
- Tangible Book Value Per Share
- JPY 2,861.84
Margins
Gross margin is 30.69%, with operating margin of 6.91%, and net profit margin of 7.21%.
- Gross Margin
- 30.69%
- Operating Margin
- 6.91%
- Pretax Margin
- 10.52%
- Net Profit Margin
- 7.21%
- EBITDA Margin
- 12.12%
- EBIT Margin
- 7.23%
Analyst Forecast
The average price target for Riken Vitamin Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 3.11%
- EPS Growth Forecast
- -17.81%
Scores
- Smart Score
- ―
- AI Score
- 77